Page last updated: 2024-10-31

midazolam and Hirschsprung Disease

midazolam has been researched along with Hirschsprung Disease in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Hirschsprung Disease: Congenital MEGACOLON resulting from the absence of ganglion cells (aganglionosis) in a distal segment of the LARGE INTESTINE. The aganglionic segment is permanently contracted thus causing dilatation proximal to it. In most cases, the aganglionic segment is within the RECTUM and SIGMOID COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pfefferkorn, MD1
Croffie, JM1
Corkins, MR1
Gupta, SK1
Fitzgerald, JF1

Other Studies

1 other study available for midazolam and Hirschsprung Disease

ArticleYear
Impact of sedation and anesthesia on the rectoanal inhibitory reflex in children.
    Journal of pediatric gastroenterology and nutrition, 2004, Volume: 38, Issue:3

    Topics: Adjuvants, Anesthesia; Adolescent; Anal Canal; Anesthesia, General; Atropine; Child; Child, Preschoo

2004